Inflammation in Vascular Disease
Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
| Condition(s) | Vascular Diseases, Atherosclerosis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease. |
| Who can participate | Inclusion Criteria: * Patient is planned to undergo vascular surgery. * Signed informed consent has been obtained from the patient. Exclusion Criteria: * Patient has difficulty to understand information. * Patients under 18 years of age. * Patients participating in any drug-related study. |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Göteborg University |
| Locations | Gothenburg, Vastragotaland, Sweden |
| Start date | 2019-09-02 |
| NCT ID | NCT03732612 |
| Official listing | https://clinicaltrials.gov/study/NCT03732612 |